help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on May 25, 2006, doi:10.1164/rccm.200511-1816OC
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200511-1816OCv1
174/5/530    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, T.
Right arrow Articles by Ishigami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, T.
Right arrow Articles by Ishigami, A.
American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 530-537, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200511-1816OC


Original Article

Senescence Marker Protein-30 Protects Mice Lungs from Oxidative Stress, Aging, and Smoking

Tadashi Sato, Kuniaki Seyama, Yasunori Sato, Hiroaki Mori, Sanae Souma, Taeko Akiyoshi, Yuzo Kodama, Takanori Mori, Sataro Goto, Kazuhisa Takahashi, Yoshinosuke Fukuchi, Naoki Maruyama and Akihito Ishigami

Department of Respiratory Medicine, Juntendo University, School of Medicine; Department of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo; and Department of Biochemistry, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan

Correspondence and requests for reprints should be addressed to Tadashi Sato, M.D., Department of Respiratory Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan. E-mail: satotada{at}med.juntendo.ac.jp


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Rationale: Senescence marker protein-30 (SMP30) is a multifunctional protein providing protection to cellular functions from age-associated deterioration. We previously reported that SMP30 knockout (SMP30Y/–) mice are capable of being novel models for senile lung with age-related airspace enlargement and enhanced susceptibility to harmful stimuli.

Objectives: Aging and smoking are considered as major contributing factors for the development of pulmonary emphysema. We evaluated whether SMP30Y/– mice are susceptible to oxidative stress associated with aging and smoking.

Methods: Age-related changes of protein carbonyls in lung tissues from the wild-type (SMP30Y/+) and SMP30Y/– mice were evaluated. Both strains were exposed to cigarette smoke for 8 wk. Histopathologic and morphologic evaluations of the lungs, protein carbonyls and malondialdehyde in the lung tissues, total glutathione content in the bronchoalveolar lavage fluid, and degree of apoptosis of lung cells were determined.

Measurements and Main Results: In the lungs of SMP30Y/– mice, protein carbonyls tended to increase with aging and were significantly higher than the age-matched SMP30Y/+ mice. Cigarette smoke exposure generated marked airspace enlargement (23.3% increase of the mean linear intercepts) with significant parenchymal destruction in the SMP30Y/– mice but not in the SMP30Y/+ mice (5.4%). The protein carbonyls, malondialdehyde, total glutathione, and apoptosis of lung cells were significantly increased after 8-wk exposure to cigarette smoke in the SMP30Y/– mice.

Conclusions: Our results suggest that SMP30 protects mice lungs from oxidative stress associated with aging and smoking. The SMP30Y/– mice could be useful animal models for investigating age-related lung diseases, including cigarette smoke–induced pulmonary emphysema.

Key Words: aging • oxidative stress • pulmonary emphysema • senescence marker protein-30 • smoking

Senescence marker protein-30 (SMP30), a 34-kD protein originally identified from the rat liver, is a novel molecule that decreases with age in an androgen-independent manner, suggesting its possible role in age-related physiologic and pathologic conditions (13). We demonstrated that SMP30 is widely expressed in vertebrates and that the amino acid alignment is highly conserved (2, 4). In mice, SMP30 transcripts are detected in various organs, including the liver, kidney, cerebrum, testis, and lung (5). In humans, the SMP30 gene is located in the p11.3–q11.2 segment of the X chromosome (6). To clarify the physiologic role of SMP30 in age-associated organ disorders, the SMP30 knockout (SMP30Y/–) mouse was developed with gene targeting from C57BL6 mice (7). We revealed that SMP30Y/– mice are viable and fertile but have reduced weight gain and shorter life span than the wild-type (SMP30Y/+) mice (8). Hepatocytes isolated from SMP30Y/– mice were shown to be highly susceptible to tumor necrosis factor-{alpha} and Fas-mediated apoptosis (7). Furthermore, exogenously induced SMP30 was shown to increase Ca2+ efflux by activating the calmodulin-dependent Ca2+ pump in HepG2 cells and thus to confer resistance to cell death caused by an increase in intracellular Ca2+ concentration (9). These findings suggest that SMP30 protects cells and organs from various injuries during the course of life.

There are many studies concerned with the relationship between aging and oxidative stress. Moderate oxidative stress may gradually develop with age because plasma levels of lipoperoxidation products and antioxidant enzyme activities in red blood cells increase with aging, whereas plasma levels of nutritional antioxidants decrease (10). The lungs are persistently exposed to oxidants generated endogenously from phagocytes and other cell types or exogenously from air pollutants or cigarette smoke (11). Pulmonary emphysema is an age-related lung disease that occurs after a prolonged period of cigarette smoking. Because cigarette smoke contains around 1017 oxidant molecules per puff and generates oxidant/antioxidant imbalance in the lungs, oxidative stress is postulated to play an important role in the pathogenesis of emphysema (11). In patients with chronic obstructive pulmonary disease, biomarkers of oxidative stress, such as protein carbonyls and lipid peroxidation products, are reported to be elevated in the lungs (12) and respiratory muscles (13).

We previously reported that SMP30Y/– mice develop peripheral airspace enlargement without alveolar destruction and may thus be a novel model for senile lung (5). We hypothesized that SMP30Y/– mice may be susceptible to oxidative stress with aging. Furthermore, SMP30Y/– mice may be vulnerable to cigarette smoke exposure and generate pulmonary emphysema. In this study, we investigated the age-related changes of protein carbonyls in the lungs of SMP30Y/– and SMP30Y/+ mice and pathologically evaluated the effect of cigarette smoke exposure to the lungs and biomarkers of oxidative stress.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals
We used SMP30Y/– and SMP30Y/+ mice to investigate the age-related changes of mice lungs with 1-, 3-, 6-, and 12-mo-old mice (n = 5 for each group). We used 3-mo-old mice (n = 6 for each group) for the smoking experiment. Animal experimentation was approved by the Animal Care and Use Committee of Tokyo Metropolitan Institute of Gerontology and by Juntendo University, School of Medicine.

Preparation and Morphologic Evaluation of the Lungs
Mice were killed, and the lungs were processed as described previously (14). The lungs were lavaged with 0.5 ml of phosphate-buffered saline through an intratracheal cannula four times. The bronchoalveolar lavage fluid (BALF) was pooled, and total cell counts and cell populations in each BALF specimen were determined. The BALF was centrifuged, and the supernatant was collected for biochemical analysis.

Airspace size was assessed by determining the mean linear intercepts (MLI) according to the method previously described (15). The destructive index (DI) was determined to evaluate the severity of alveolar wall destruction (16). A DI value greater than 10% was considered to have significant destruction of the lung parenchyma (17).

Determination of Protein Carbonyls in the Lungs
The measurement of protein carbonyls in the supernatant of lung homogenates was conducted with a spectrophotometer as described previously (1820). To confirm the specificity of the reaction of the proteins with 2,4-dinitrophenylhydrazine (DNPH), the lung extracts of SMP30Y/– mice were pretreated with sodium borohydride to reduce the carbonyls in the experiment as described previously (20). The absorbance of the spectrophotometric measurement of carbonyls was reduced to 16% with treatment, confirming the validity of the method.

Immunohistochemical Staining for Protein Carbonyls in the Lungs
Protein carbonyls were identified immunohistochemically with paraffin-embedded lung sections using specific antiserum against DNPH prepared with rabbits as described previously (20). The sections were incubated with DNPH solution for 30 min and then with anti-DNPH antibody for 1 h at room temperature. The sections were incubated with biotinylated anti-rabbit IgG antibody (Vector, Burlingame, CA). Antibody binding was detected using the Elite ABC Kit (Vector) and 3,3-diaminobenzidine tetrahydrochloride as the chromogen according to the manufacturer's instructions. As a negative control, the sections were incubated in 2% HCl without DNPH for 30 min before incubation with the primary antibody or in a solution containing 2% bovine serum albumin and 2% normal goat serum instead of the polyclonal anti-DNPH antibody. All the sections were counterstained with hematoxylin.

Chronic Exposure to Cigarette Smoke
Mice were exposed to cigarette smoke for 8 wk using the commercially marketed Peace nonfilter cigarettes (29 mg of tar and 2.5 mg of nicotine per cigarette; Japan Tobacco, Inc., Tokyo, Japan) and the Tobacco Smoke Inhalation Experiment System for small animals (Model SIS-CS; Shibata Scientific Technology, Tokyo, Japan) as described previously (14). We used 2.5% cigarette smoke diluted with compressed air (mass concentration of total particulate matter, 40.6 mg/m3). Three-month-old mice were exposed to diluted cigarette smoke (study group) or fresh air (control group) for 30 min/d, 5 d/wk, and for 8 wk.

Determination of Malondialdehyde in the Lungs
The measurement of malondialdehyde (MDA) in the supernatant of lung homogenates was performed using the Lipid Peroxidation Assay Kit (Calbiochem, San Diego, CA) according to the manufacturer's instructions.

Determination of Glutathione in the BALF
Total glutathione and oxidized glutathione contents in the BALF supernatants were measured using the Total Glutathione Quantification Kit (Dojindo Molecular Technologies, Kumamoto, Japan) according to the manufacturer's instructions.

Evaluation of Apoptosis with Immunohistochemistry for Anti–Single-stranded DNA and Anti–Activated Caspase-3 Antibodies
Apoptosis of lung cells was examined with immunohistochemistry using a rabbit polyclonal antibody against the single-stranded DNA (ssDNA; Dako Cytomation, Carpinteria, CA) and anti–activated caspase-3 (Cell Signaling, Beverly, MA) as described previously (14).

Protein Assays
Total protein concentration was measured using the BCA Protein Assay Kit (Pierce, Rockford, IL) according to the manufacturer's instructions.

Statistical Analysis
The statistical significance of the data was determined using analysis of variance followed by Tukey's multiple comparison test. When applicable, the Mann-Whitney test was used. A p value of less than 0.05 was considered significant.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Age-related Changes in Body Weight, Morphometry of the Lungs, and Protein Carbonyls
Body weights increased with age in the SMP30Y/+ and SMP30Y/– mice, and there were no significant changes between both strains up to 6 mo of age. At 12 mo of age, the body weight of the SMP30Y/– mice were significantly less than that of the SMP30Y/+ mice (Table 1). Compared with the SMP30Y/+ mice, the SMP30Y/– mice had significantly greater MLI from 3 to 12 mo of age. There was a significant increase of MLI with aging in the lungs of the SMP30Y/– mice. On the other hand, the DI scores in both groups at every age were less than 10%, and no significant differences between the groups were recorded (Table 1). There were no inflammatory findings in the alveoli in both groups on histologic examination (data not shown).


View this table:
[in this window]
[in a new window]
 
TABLE 1. AGE-RELATED CHANGES OF BODY WEIGHT AND LUNG MORPHOMETRY IN SMP30Y/+ AND SMP30Y/– MICE

 
We assessed protein oxidation in the lungs of SMP30Y/+ and SMP30Y/– mice by measuring the protein carbonyls, which are known as sensitive biomarkers of oxidative stress (21). In the lungs of SMP30Y/– mice, protein carbonyls were significantly increased in comparison with those of age-matched SMP30Y/+ mice. In addition, protein carbonyls tended to increase with age and significantly increased at 12 mo of age as compared with 1 mo of age (Figure 1). We performed immunohistochemistry with anti-DNPH antibody to detect the localization of protein carbonyls in the lungs and demonstrated that the majority of the protein carbonyls was evenly distributed and diffused in both strains but was apparently stronger in the SMP30Y/– mice (Figure 2).


Figure 1
View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Age-related changes of protein carbonyls in the lungs of SMP30Y/+ and SMP30Y/– mice. In the lungs of the SMP30Y/– mice, protein carbonyls tended to increase with age ({dagger}p < 0.05, compared with 1 mo of age) and were significantly greater than those of the age-matched SMP30Y/+ mice (*p < 0.05). Values are presented as mean ± SD (n = 5 for each group).

 

Figure 2
View larger version (106K):
[in this window]
[in a new window]
 
Figure 2. Immunohistochemistry for protein carbonyls in the lungs of SMP30Y/+ (A, C, and E) and SMP30Y/– (B, D, and F) mice (original magnification: x100). Insets are magnified views of the alveolar region (x400). Anti–2,4-dinitrophenylhydrazine (-DNPH) antibody analysis revealed that protein carbonyls were largely evenly and diffusely distributed in the lung tissues of both strains but apparently were stronger in the SMP30Y/– mice (A and B). As a control for immunostaining of the lung tissues, avoiding the derivatization process (C and D) and removing primary anti-DNPH antibody (E and F) resulted in the elimination of positive immunostaining.

 
Effect of Cigarette Smoke Exposure on the Morphometry of the Lungs
The body weights did not change significantly between the SMP30Y/+ and SMP30Y/– mice before and after exposure to cigarette smoke for 8 wk. In addition, exposure to cigarette smoke had no influence on body weight gain in both strains as compared with the air-exposed groups (data not shown).

Chronic exposure to cigarette smoke increased total cell counts in the BALF of both groups. No significant differences were observed in cell populations between air- and smoke-exposed mice of both strains. The total protein concentration in the BALF increased significantly in the SMP30Y/– mice after chronic exposure to cigarette smoke but did not increase in the SMP30Y/+ mice. The smoke-exposed SMP30Y/– mice demonstrated significantly higher levels of protein concentration in BALF than the smoke-exposed SMP30Y/+ mice (Table 2).


View this table:
[in this window]
[in a new window]
 
TABLE 2. EFFECT OF CHRONIC CIGARETTE SMOKE EXPOSURE ON BRONCHOALVEOLAR LAVAGE FLUID ANALYSES IN SMP30Y/+ AND SMP30Y/– MICE

 
Chronic exposure to cigarette smoke for 8 wk generated pulmonary emphysema in the SMP30Y/– mice but not in SMP30Y/+ mice. Histologic specimens of the lung tissues of smoke-exposed SMP30Y/– mice revealed marked airspace enlargement (i.e., an increase of MLI) accompanied with disruption of alveolar wall (i.e., an increase of DI; Figures 3 and 4). Morphometric examination of the lung specimen revealed that MLI was significantly greater in the smoke-exposed SMP30Y/– mice than in the air-exposed SMP30Y/– and SMP30Y/+ mice (Figure 4A): MLI increased to 23.3% in the SMP30Y/– mice after exposure to cigarette smoke and 5.4% for the SMP30Y/+ mice. Moreover, DI increased to more than 10%, a cut-off value indicating the occurrence of significant alveolar wall destruction (17), in the lungs from smoke-exposed SMP30Y/– mice, whereas no significant increase was observed in the SMP30Y/+ mice (Figure 4B).


Figure 3
View larger version (76K):
[in this window]
[in a new window]
 
Figure 3. Histologic findings of the lungs of SMP30Y/+ and SMP30Y/– mice after chronic cigarette smoke exposure (hematoxylin–eosin staining; original magnification, x50). (A and B) SMP30Y/+ mice exposed to air and cigarette smoke, respectively. (C and D) SMP30Y/– mice, exposed to air and cigarette smoke, respectively. The lungs of the SMP30Y/– mice exposed to cigarette smoke revealed marked airspace enlargement and alveolar wall destruction (D).

 

Figure 4
View larger version (25K):
[in this window]
[in a new window]
 
Figure 4. Morphometric findings of the lungs of SMP30Y/+ and SMP30Y/– mice after chronic cigarette smoke exposure. (A) Mean linear intercepts (MLI). Values are presented as mean ± SD (n = 6 for each group). In the lungs of SMP30Y/– mice exposed to cigarette smoke, MLI was significantly greater than the other groups (*p < 0.05). The MLI increased to 23.3% in the SMP30Y/– mice and to 5.4% for the SMP30Y/+ mice. The MLI in the SMP30Y/– mice exposed to air was significantly greater than that of the SMP30Y/+ mice exposed to air ({dagger}p < 0.05). (B) The destructive index (DI). Values are presented as mean ± SD (n = 6 for each group). In the lungs of the SMP30Y/– mice exposed to cigarette smoke, DI was increased more than 10% (*p < 0.05 compared with the other groups).

 
Effect of Cigarette Smoke Exposure on Oxidative Stress in the Lungs
To investigate the effect of chronic cigarette smoke exposure on oxidative injury in the lungs, we measured protein carbonyls in the lungs of SMP30Y/+ and SMP30Y/– mice after exposure to air or cigarette smoke (Figure 5). Protein carbonyls tended to increase in the lungs of both strains after cigarette smoke exposure, although no significant statistical difference was noted (p = 0.08 and 0.07 between air and smoke exposure in SMP30Y/+ and SMP30Y/– mice, respectively). Protein carbonyls were significantly increased in the lungs of smoke-exposed SMP30Y/– mice than those of the smoke-exposed SMP30Y/+ mice. We also performed immunohistochemistry with anti-DNPH antibody on lung specimens from both strains after chronic exposure to cigarette smoke. Anti-DNPH antibody demonstrated an even and diffuse distribution of protein carbonyls in the lungs of both strains after exposure to cigarette smoke (data not shown), indicating that chronic smoke exposure seems to increase oxidative stress evenly throughout the lungs.


Figure 5
View larger version (19K):
[in this window]
[in a new window]
 
Figure 5. Protein carbonyls in the lungs of SMP30Y/+ and SMP30Y/– mice after chronic cigarette smoke exposure. Protein carbonyls in the lungs of SMP30Y/– mice were significantly greater in the air- and smoke-exposed groups than those of SMP30Y/+ mice (*p < 0.05 compared with SMP30Y/+ mice air-exposed group, and {dagger}p < 0.05 compared with SMP30Y/+ mice smoke-exposed group). Values are presented as mean ± SD (n = 6 for each group).

 
We assessed lipid peroxidation in the lungs by measuring MDA (Figure 6), which is known as one of the end products derived from peroxidation of polyunsaturated fatty acids and related esters (22). Baseline levels of MDA in the lung tissues from both strains (air-exposed) were almost identical. However, MDA significantly increased in the lungs of the SMP30Y/– mice after chronic cigarette smoke exposure, whereas no increase was demonstrated in the lungs of the SMP30Y/+ mice. We did not use the conventional thiobarbituric acid method to measure the MDA because of low specificity of this method. Instead, we used a method that allows us to assay MDA selectively by reacting with N-methyl-2-phenylindole in HCl, eliminating the potential inclusion of 4-hydroxylalkenals and alkanals in the measurement. The reaction produces a chromophore with maximum absorption at 586 nm, whereas the reaction with alkanals forms a product with maximum absorption at 505 nm (23).


Figure 6
View larger version (22K):
[in this window]
[in a new window]
 
Figure 6. Malondialdehyde (MDA) in the lungs of SMP30Y/+ and SMP30Y/– mice after chronic cigarette smoke exposure. MDA was significantly increased in the lungs of SMP30Y/– mice exposed to cigarette smoke as compared with those of the air-exposed SMP30Y/+ (*p < 0.05) and SMP30Y/– ({dagger}p < 0.05) mice. Values are presented as mean ± SD (n = 6 for each group).

 
We measured the content of total glutathione in BALF (Figure 7) because it is widely recognized as a major antioxidant in the lungs (24, 25). In SMP30Y/– mice, baseline level of total glutathione in BALF tended to be greater than that of the SMP30Y/+ mice, but no statistical significance was detected (p = 0.06).Chronic cigarette smoke exposure markedly up-regulated the amount of total glutathione in BALF from the SMP30Y/– mice (p < 0.05), whereas no effect of smoke exposure on the glutathione level was revealed in the SMP30Y/+ mice (p = 0.79). We were able to detect oxidized glutathione in BALF from the cigarette smoke–exposed SMP30Y/– mice group but not from the other groups (i.e., less than the detection limit). The amount of oxidized glutathione detected in smoke-exposed SMP30Y/– mice was 7.91 nmol/mg protein (7.95% of total glutathione content).


Figure 7
View larger version (15K):
[in this window]
[in a new window]
 
Figure 7. Total glutathione content in a bronchoalveolar lavage fluid (BALF) specimen of SMP30Y/+ and SMP30Y/– mice after chronic cigarette smoke exposure. Total glutathione content was significantly up-regulated in the SMP30Y/– mice exposed to cigarette smoke as compared with the other groups (*p < 0.05). Values are presented as mean ± SD (n = 6 for each group). {dagger}Oxidized glutathione was detected only in BALF from the smoke-exposed SMP30Y/– mice but not from the other groups (i.e., less than the detection limit). The amount of oxidized glutathione detected in the smoke-exposed SMP30Y/– mice was 7.91 nmol/mg protein (7.95% of total glutathione content).

 
Effect of Cigarette Smoke Exposure on Apoptosis of Lung Cells
Apoptosis of lung cells was analyzed to investigate the mechanisms of cigarette smoke-induced emphysema in the SMP30Y/– mice. Immunohistochemical examination using anti–single-stranded DNA antibody revealed that apoptosis was widely detected in bronchial and bronchiolar epithelial cells and alveolar septal cells and was significantly increased in all areas of the lungs of the cigarette smoke–exposed SMP30Y/– mice compared with the other groups (Figures 8A and 8B). On the other hand, there was no significant difference in the ratio of apoptotic nuclei detected between the air- and smoke-exposed SMP30Y/+ mice (p = 0.09) and between the air-exposed SMP30Y/+ and SMP30Y/– mice (p = 0.07). Chronic cigarette smoke–induced increase in apoptosis was further confirmed with immunohistochemical analysis of caspase-3: Activated caspase-3 was detected in the lungs of cigarette smoke–exposed SMP30Y/– mice (Figure 8C) but not in the other groups (data not shown).


Figure 8
View larger version (56K):
[in this window]
[in a new window]
 
Figure 8. Immunohistochemical detection of apoptosis in the lungs of SMP30Y/+ and SMP30Y/– mice after cigarette smoke exposure. (A) Representative results of immunohistochemistry for single-stranded DNA (original magnification: x50). Insets are magnified views of the alveolar region (x200). Note that positive immunostaining (nucleus stained brown) for DNA strand breaks was revealed in airway epithelial and alveolar wall cells in the lungs of SMP30Y/– mice after cigarette smoke exposure compared with the other groups. (B) Immunoreactive nuclei for anti–single-stranded DNA antibody were counted in three areas and expressed as the positive ratio (%) of total nuclei counted. AC = alveolar septal cells; CB = bronchial cells in the central airway; PB = bronchiolar cells adjacent to alveolar duct. The ratio of positively immunostained nuclei in all areas of the lungs of cigarette smoke–exposed SMP30Y/– mice was significantly higher than those of the other groups (*p < 0.001). Values are presented as mean ± SD (n = 6 for each group). (C) Representative results of immunohistochemistry for the activated caspase-3 in the lungs of the SMP30Y/– mice after cigarette smoke exposure (left: bronchial cells; right: alveolar septal cells; original magnification x200). Positive reactions were identified in the lungs of cigarette smoke–exposed SMP30Y/– mice but were rarely seen in the lungs of the other groups.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We have demonstrated that the oxidative stress in the lungs is greater in the SMP30Y/– mice than the SMP30Y/+ mice and tends to gradually increase in the SMP30Y/– mice as determined from measuring the protein carbonyls, one of the biomarkers for oxidative stress (26, 27), in the lungs. We did not measure the age-related changes of lipid peroxidation as another biomarker for oxidative stress and glutathione as a major antioxidant in BALF. At 5 mo of age, however, there was no significant statistical difference between SMP30Y/+ and SMP30Y/– mice in lipid peroxidation of the lungs (Figure 6; p = 0.76) and glutathione in BALF (Figure 7; p = 0.06). In contrast, chronic cigarette smoke exposure for 8 wk resulted in a marked increase of lipid peroxidation and up-regulation of glutathione, with the tendency of a greater increase of protein carbonyls in the SMP30Y/– mice, but it did not generate significant influence on these biomarkers of oxidative stress in the SMP30Y/+ mice. Our results indicate that the lack of a SMP30 molecule brings forth an endogenous mild oxidative stress situation in the lungs and makes the lungs highly susceptible to oxidative stress induced by smoke exposure even if exogenous oxidative stress is so mild that it does not generate oxidative proteins and lipids and up-regulate glutathione in BALF of the SMP30Y/+ mice. In this context, SMP30Y/– mice seem to be an excellent tool for investigating the pathophysiology of the lung associated with oxidant/antioxidant imbalance like smoke-induced emphysema and aging-related conditions like the senile lung.

The precise function of SMP30 in terms of oxidant and antioxidant balance remains undetermined. We demonstrated previously that SMP30 is localized in the nuclei in addition to the cytoplasm of cultured mouse hepatocytes and is similar in its amino acid sequence to bacterial and yeast RNA polymerases (28). Accordingly, SMP30 may regulate gene expression, and the lack of SMP30 may cause down-regulation of antioxidant enzymes. It has recently been reported that with gene targeting of the Nrf2 (nuclear factor, erythroid-derived 2, like 2), a transcription factor regulating gene expression involved in antioxidant defense, inflammation, and cellular apoptosis, plays an important role in the development of smoke-induced emphysema (29): Nrf2–/– mice were demonstrated to be extremely susceptible to cigarette smoke–induced emphysema after 6 mo of exposure. Glutathione is a potent antioxidant in the lungs and is highly concentrated in the epithelial lining fluid (24, 25). The transcription of the gene for {alpha}-glutamylcysteine synthetase, the rate-limiting enzyme for glutathione synthesis, is markedly up-regulated by chronic cigarette smoke exposure (30). Cigarette smoke–induced up-regulation of {gamma}-glutamylcysteine synthetase has been reported to be mediated by the redox-sensitive transcription factor, activating protein-1 (31, 32). Although we did not directly measure enzyme activities, SMP30 seems not to be involved in the regulation of {gamma}-glutamylcysteine synthetase because the glutathione content in BALF was markedly increase after 8 wk of smoke exposure in the SMP30Y/– mice. Moreover, the activity of glutathione reductase is not likely to be affected in the SMP30Y/– mice because the fraction of the oxidized form of glutathione is approximately 8% of the increased total glutathione content of the BALF. Because {gamma}-glutamylcysteine synthetase and glutathione reductase are involved in the Nrf2 pathway (29), SMP30 may not have functional cross-talk with Nrf2. On the other hand, we previously reported lipid deposition and degeneration of mitochondria in the liver, kidney, and submandibular gland of SMP30Y/– mice (8, 33, 34). The mitochondrion is speculated to be the main source of endogenous intracellular oxidant through a leak of an electron from the mitochondrial respiratory chain, but it has antioxidant enzymes (Mn-superoxide dismutase and glutathione peroxidase) that can attenuate oxidative stress. Recent studies have highlighted the important role of mitochondrial proteolytic enzymes in providing resistance to oxidative stress (35). Accordingly, the mitochondrial degeneration observed in the SMP30Y/–mice may be involved in the susceptibility of the lungs to oxidative stress. However, our preliminary electron microscopic analysis of the lungs did not detect structural abnormalities in the SMP30Y/– mice as compared with lungs of the SMP30Y/+ mice (data not shown). Further studies are needed to elucidate the precise role of SMP30 in oxidant/antioxidant balance by examining the gene expression profiles of the lungs from the SMP30Y/– mice with special reference to mitochondrial antioxidant enzymes and proteolytic enzymes.

We previously reported that SMP30Y/– is a novel murine model of senile lung because senile lungs develop spontaneous airspace enlargement without parenchymal destruction (5). This was confirmed in this study because SMP30Y/– mice showed significantly greater MLI at 3 mo of age than SMP30Y/+ mice. The SMP30Y/– mouse seems to be not only a murine model of senile lung but also a murine model of cigarette smoke–induced emphysema. SMP30Y/– mice are markedly susceptible to cigarette smoke, and smoke exposure for 8 wk was sufficient to develop cigarette smoke–induced pulmonary emphysema with marked airspace enlargement and parenchymal destruction. Although some animal models have been reported to develop cigarette smoke–induced pulmonary emphysema, most animal models required a longer period of cigarette smoke exposure, generally 6 or 7 mo, to generate smoke-induced emphysema. Because cigarette smoke–induced pulmonary emphysema in humans usually occurs in the elderly population, we considered that aging of the lung can be an important factor and should be incorporated into the experimental animal model for such condition. The effect of age on lung morphometry (36) and in the development of chronic cigarette smoke–induced lung pathology (37) has been reported. In BALB/cNNia mice, alveolar multiplication seemed to be completed by 38 d of age; interalveolar pore formation increased until 9 mo of age; and lung volume, alveolar surface area, and total volume of alveolar wall increased with age between 9 and 28 mo of age, which is postulated to be attributed to aging of the lungs (36). It was reported that in C57BL/6 mice, the older mice (8–10 mo of age) developed pathologic manifestations closely resembling pulmonary fibrosis and developed peribronchiolar and perivascular accumulations of lymphocytes and macrophages in the lungs after 9 mo exposure to cigarette smoke, whereas young mice (2 mo of age) revealed accumulations of inflammatory cells without fibrosis (37). Among other mice models for emphysema, the klotho mutant mouse and senescence-accelerated mouse (SAM) are unique due to their biological aging. The homozygous mutant klotho mice demonstrate a shorter life span and exhibit pulmonary emphysema, arteriosclerosis, osteoporosis, skin atrophy, and ectopic calcifications. However, the klotho mutant mice are distinct in developing pulmonary emphysema spontaneously without smoking (38). On the other hand, the SAM mice are the naturally occurring animal models for accelerated aging after normal development and maturation (39). We have recently reported that the SAMP1 mouse is capable of developing smoke-induced emphysema after 8 wk of cigarette smoke exposure. We also demonstrated that SAMP1 mice can be used for experiments involving therapeutic intervention because the development of smoke-induced emphysema was successfully prevented with concomitant administration of tomato juice, which contains a potent nutritional antioxidant, lycopene (14). In this context, SMP30Y/– mice further illustrate the significance of biological aging of the lungs in the development of cigarette smoke–induced pulmonary emphysema and may be considered as valuable animal models for smoke-induced emphysema.

Several mechanisms are likely to be involved in the development of cigarette smoke–induced pulmonary emphysema. An increase of oxidative stress to the lungs may be associated with many of the pathogenic processes, such as direct injury to lung cells, mucus hypersecretion, inactivation of antiproteases, enhancing lung inflammation through activation of redox-sensitive transcription factors, and apoptosis of lung cells (11). In the present study, chronic smoke exposure increased total cell count in SMP30Y/+ and SMP30Y/– mice. On the other hand, SMP30Y/– mice showed total protein level in BALF increased twofold from the baseline level after smoke exposure, whereas no change was detected in SMP30Y/+ mice. These findings may suggest that the inflammation in the lungs induced by chronic smoke exposure may be more pronounced in SMP30Y/– mice than in SMP30Y/+ mice, although we did not measure any other parameters of inflammation. Pulmonary emphysema can be generated without apparent inflammation, and it has recently been recognized that alveolar cell apoptosis could be one of the crucial process in emphysema: Direct instillation of activated caspase-3 (40) or vascular endothelial cell apoptosis resulting from the blockade of the vascular endothelial growth factor receptors (41) has been demonstrated to result in emphysema. As we reported previously that hepatocytes from SMP30Y/– mice are susceptible to apoptosis (7), we confirmed in this study that lungs cells are also susceptible to apoptosis triggered by oxidative stress. Accordingly, SMP30Y/– mice may be ideal animal models for cigarette smoke–induce emphysema in terms of investigating mutual interactions among apoptosis, oxidative stress, and inflammation, which is proposed as the mechanism for irreversible progression of parenchymal destruction (42, 43). Recently, up-regulation of lung ceramide, a second messenger lipid, has been reported to be a key pathogenic element in these mutual interactions (44). Because we have previously demonstrated that abnormal lipid metabolism occurs in the liver of the SMP30Y/– mice (8), we need to examine whether SMP30 may be involved in the regulation of lung ceramide as the next step of our study.


    Acknowledgments
 
The authors thank Dr. Toshio Kumasaka, Department of Pathology, Juntendo University, School of Medicine, for advice and technical help.


    FOOTNOTES
 
Supported by Grant-in-Aid for Scientific Research No. 13470130 (Y.F.) and No. 15390259 (Y.F.); by the High Technology Research, Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology, Smoking Science Foundation No. FP00404086 (N.M.); by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare, Japan (K.S.); and by the Institute for Environmental and Gender-Specific Medicine, Juntendo University, Graduate School of Medicine (K.S.).

This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org

Originally Published in Press as DOI: 10.1164/rccm.200511-1816OC on May 25, 2006

Conflict of Interest Statement: None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

Received in original form November 28, 2005; accepted in final form May 24, 2006


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1992;1116:122–128.[Medline]
  2. Fujita T, Shirasawa T, Uchida K, Maruyama N. Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30) and its tissue distribution. Biochim Biophys Acta 1992;1132:297–305.[Medline]
  3. Fujita T, Shirasawa T, Uchida K, Maruyama N. Gene regulation of senescence marker protein-30 (SMP30): coordinated up-regulation with tissue maturation and gradual down-regulation with aging. Mech Ageing Dev 1996;87:219–229.[CrossRef][Medline]
  4. Fujita T, Shirasawa T, Maruyama N. Isolation and characterization of genomic and cDNA clones encoding mouse senescence marker protein-30 (SMP30). Biochim Biophys Acta 1996;1308:49–57.[Medline]
  5. Mori T, Ishigami A, Seyama K, Onai R, Kubo S, Shimizu K, Maruyama N, Fukuchi Y. Senescence marker protein-30 knockout mouse as a novel murine model of senile lung. Pathol Int 2004;54:167–173.[CrossRef][Medline]
  6. Fujita T, Mandel JL, Shirasawa T, Hino O, Shirai T, Maruyama N. Isolation of cDNA clone encoding human homologue of senescence marker protein-30 (SMP30) and its location on the X chromosome. Biochim Biophys Acta 1995;1263:249–252.[Medline]
  7. Ishigami A, Fujita T, Handa S, Shirasawa T, Koseki H, Kitamura T, Enomoto N, Sato N, Shimosawa T, Maruyama N. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. Am J Pathol 2002;161:1273–1281.[Abstract/Free Full Text]
  8. Ishigami A, Kondo Y, Nanba R, Ohsawa T, Handa S, Kubo S, Akita M, Maruyama N. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun 2004;315:575–580.[CrossRef][Medline]
  9. Fujita T, Inoue H, Kitamura T, Sato N, Shimosawa T, Maruyama N. Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca(2+)-pumping activity in Hep G2 cells. Biochem Biophys Res Commun 1998;250:374–380.[CrossRef][Medline]
  10. Junqueira VB, Barros SB, Chan SS, Rodrigues L, Giavarotti L, Abud RL, Deucher GP. Aging and oxidative stress. Mol Aspects Med 2004; 25:5–16.[CrossRef][Medline]
  11. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2: 50–60.[Abstract/Free Full Text]
  12. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, De Boer WI. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:490–495.[Abstract/Free Full Text]
  13. Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, Gea J. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:1116–1124.[Abstract/Free Full Text]
  14. Kasagi S, Seyama K, Mori H, Souma S, Sato T, Akiyoshi T, Suganuma H, Fukuchi Y. Tomato juice prevents from developing emphysema induced by chronic exposure to tobacco smoke in senescence-accelerated mouse P1 strain. Am J Physiol Lung Cell Mol Physiol 2006;290: 396–404.
  15. Thurlbeck WM. The internal surface area of nonemphysematous lungs. Am Rev Respir Dis 1967;95:765–773.[Medline]
  16. Eidelman DH, Bellofiore S, Chiche D, Cosio MG, Martin JG. Behavior of morphometric indices in pancreatic elastase-induced emphysema in rats. Lung 1990;168:159–169.[Medline]
  17. Teramoto S, Fukuchi Y, Uejima Y, Teramoto K, Oka T, Orimo H. A novel model of senile lung: senescence-accelerated mouse (SAM). Am J Respir Crit Care Med 1994;150:238–244.[Abstract]
  18. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464–478.[Medline]
  19. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346–357.[Medline]
  20. Nakamura A, Goto S. Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis. J Biochem (Tokyo) 1996;119:768–774.[Abstract/Free Full Text]
  21. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003;9:169–176.[CrossRef][Medline]
  22. Liu J, Yeo HC, Doniger SJ, Ames BN. Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal Biochem 1997;245:161–166.[CrossRef][Medline]
  23. Erdelmeier I, Gerard-Monnier D, Yadan JC, Chaudiere J. Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals: mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998;11:1184–1194.[CrossRef][Medline]
  24. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987;63:152–157.[Abstract/Free Full Text]
  25. Teramoto S, Fukuchi Y, Uejima Y, Teramoto K, Orimo H. Biochemical characteristics of lungs in senescence-accelerated mouse (SAM). Eur Respir J 1995;8:450–456.[Abstract]
  26. Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000;899: 191–208.[Medline]
  27. Goto S, Nakamura A. Age-associated, oxidatively modified proteins: a critical evaluation. Age (Omaha) 1997;20:81–89.[CrossRef]
  28. Ishigami A, Handa S, Maruyama N, Supakar PC. Nuclear localization of senescence marker protein-30, SMP30, in cultured mouse hepatocytes and its similarity to RNA polymerase. Biosci Biotechnol Biochem 2003;67:158–160.[CrossRef][Medline]
  29. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004;114:1248–1259.[CrossRef][Medline]
  30. Rahman I, Smith CA, Lawson MF, Harrison DJ, MacNee W. Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett 1996;396: 21–25.[CrossRef][Medline]
  31. Rahman I, Antonicelli F, MacNee W. Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-alpha and dexamethasone in human alveolar epithelial cells. J Biol Chem 1999; 274:5088–5096.[Abstract/Free Full Text]
  32. Rahman I, Smith CA, Antonicelli F, MacNee W. Characterisation of gamma-glutamylcysteine synthetase-heavy subunit promoter: a critical role for AP-1. FEBS Lett 1998;427:129–133.[CrossRef][Medline]
  33. Maruyama N, Ishigami A, Kuramoto M, Handa S, Kubo S, Imasawa T, Seyama K, Shimosawa T, Kasahara Y. Senescence marker protein-30 knockout mouse as an aging model. Ann N Y Acad Sci 2004;1019:383–387.[CrossRef][Medline]
  34. Ishii K, Tsubaki T, Fujita K, Ishigami A, Maruyama N, Akita M. Immunohistochemical localization of senescence marker protein-30 (SMP30) in the submandibular gland and ultrastructural changes of the granular duct cells in SMP30 knockout mice. Histol Histopathol 2005;20:761–768.[Medline]
  35. Bota DA, Davies KJ. Protein degradation in mitochondria: implications for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders. Mitochondrion 2001;1:33–49.[CrossRef][Medline]
  36. Kawakami M, Paul JL, Thurlbeck WM. The effect of age on lung structure in male BALB/cNNia inbred mice. Am J Anat 1984;170:1–21.[CrossRef][Medline]
  37. Matulionis DH. Chronic cigarette smoke inhalation and aging in mice: 1. Morphologic and functional lung abnormalities. Exp Lung Res 1984; 7:237–256.[Medline]
  38. Suga T, Kurabayashi M, Sando Y, Ohyama Y, Maeno T, Maeno Y, Aizawa H, Matsumura Y, Kuwaki T, Kuro OM, et al. Disruption of the klotho gene causes pulmonary emphysema in mice: defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol 2000;22:26–33.[Abstract/Free Full Text]
  39. Takeda T, Hosokawa M, Higuchi K, Hosono M, Akiguchi I, Katoh H. A novel murine model of aging, Senescence-Accelerated Mouse (SAM). Arch Gerontol Geriatr 1994;19:185–192.[Medline]
  40. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 2003;28:555–562.[Abstract/Free Full Text]
  41. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106: 1311–1319.[Medline]
  42. Tuder RM, Petrache I, Elias JA, Voelkel NF, Henson PM. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003;28: 551–554.[Free Full Text]
  43. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003;29:88–97.[Abstract/Free Full Text]
  44. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005;11:491–498.[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200511-1816OCv1
174/5/530    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, T.
Right arrow Articles by Ishigami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, T.
Right arrow Articles by Ishigami, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society